Search research articles
Contact Us
Filters
Showing results (151-160 of 347) with videos related to
Page
of 35
Sort By:
BMJ Open
|
December 16, 2025
Virtual reality-based cognitive rehabilitation programme to support employment in patients with breast cancer: protocol for the Cog-RV pilot study
Ilona Vieira Jales, Emilie Hummel, Bénédicte Clarisse, et al.
JAMA Network Open
|
August 19, 2024
Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis
Marie Lange, Justine Lequesne, Agnes Dumas, et al.
Clinical Chemistry
|
February 11, 2020
Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma
Nicolas Vigneron, Mégane Vernon, Matthieu Meryet-Figuière, et al.
The Oncologist
|
October 10, 2013
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy
Mario Campone, Dominique Berton-Rigaud, Florence Joly-Lobbedez, et al.
The Journal of Investigative Dermatology
|
September 1, 2015
Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients
Claire Regazzetti, Florence Joly, Carine Marty, et al.
Current Oncology (Toronto, Ont.)
|
April 21, 2022
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations
Zoé Neviere, Elodie Coquan, Pierre-Emmanuel Brachet, et al.
The Oncologist
|
October 31, 2014
A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer
Nadine Houédé, Marina Pulido, Loic Mourey, et al.
Anti-Cancer Drugs
|
July 29, 2011
Evaluation of current practice: management of chemotherapy-related toxicities
Stéphanie Lheureux, Bénédicte Clarisse, Vincent Launay-Vacher, et al.
Frontiers in Oncology
|
June 18, 2024
Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study
Marin Guigo, Mohammed Sali Dauda, Justine Lequesne, et al.
Oncology and Therapy
|
March 7, 2017
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
Véronique Diéras, Thomas Bachelot, Mario Campone, et al.
Page
of 35
Search research articles
Search
Showing results (151-160 of 347) with videos related to
Sort By:
Page
of 35
BMJ Open
|
December 16, 2025
Virtual reality-based cognitive rehabilitation programme to support employment in patients with breast cancer: protocol for the Cog-RV pilot study
Ilona Vieira Jales, Emilie Hummel, Bénédicte Clarisse, et al.
JAMA Network Open
|
August 19, 2024
Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis
Marie Lange, Justine Lequesne, Agnes Dumas, et al.
Clinical Chemistry
|
February 11, 2020
Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma
Nicolas Vigneron, Mégane Vernon, Matthieu Meryet-Figuière, et al.
The Oncologist
|
October 10, 2013
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy
Mario Campone, Dominique Berton-Rigaud, Florence Joly-Lobbedez, et al.
The Journal of Investigative Dermatology
|
September 1, 2015
Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients
Claire Regazzetti, Florence Joly, Carine Marty, et al.
Current Oncology (Toronto, Ont.)
|
April 21, 2022
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations
Zoé Neviere, Elodie Coquan, Pierre-Emmanuel Brachet, et al.
The Oncologist
|
October 31, 2014
A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer
Nadine Houédé, Marina Pulido, Loic Mourey, et al.
Anti-Cancer Drugs
|
July 29, 2011
Evaluation of current practice: management of chemotherapy-related toxicities
Stéphanie Lheureux, Bénédicte Clarisse, Vincent Launay-Vacher, et al.
Frontiers in Oncology
|
June 18, 2024
Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study
Marin Guigo, Mohammed Sali Dauda, Justine Lequesne, et al.
Oncology and Therapy
|
March 7, 2017
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
Véronique Diéras, Thomas Bachelot, Mario Campone, et al.
Page
of 35